By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Agenus (Formerly known as Antigenics Inc. - New York) 

Corporate Headquarters
3 Forbes Road
Lexington  Massachusetts  02421-7305  U.S.A.
Phone: 781-674-4400 Fax: 781-674-4200


SEARCH JOBS


Industry
Biotechnology

Segment
Biotechnology





Company News
Agenus (AGEN) Appoints Jean-Marie Cuillerot, M.D. As Vice President And Global Head Of Clinical Development 7/6/2016 9:29:25 AM
Agenus (AGEN) Announces Commencement Of Phase I/II Clinical Trial Of Anti-GITR Checkpoint Antibody INCAGN1876 In Patients With Solid Tumors 6/22/2016 8:18:46 AM
Agenus (AGEN) Reports Fourth Quarter And Full Year 2015 Financial And Operational Results And Recent Highlights 3/3/2016 11:06:09 AM
Agenus (AGEN) Bags Novel Antibodies to Immuno-oncology Target for $44 Million+ 7/20/2015 5:55:54 AM
Agenus (AGEN) To Present At The Cowen and Company 35th Annual Health Care Conference 2/26/2015 11:33:42 AM
Agenus (AGEN) Reports Third Quarter 2014 Financial Results 10/31/2014 9:17:44 AM
Agenus (AGEN) Reports Second Quarter 2014 Financial Results 7/24/2014 11:23:32 AM
Massachusetts' Agenus (AGEN) Touts Positive Phase 2 Data From HerpV Study 6/26/2014 6:02:11 AM
Agenus (Formerly known as Antigenics Inc. - New York) (AGEN) Completes Acquisition of 4-Antibody AG 2/13/2014 8:16:39 AM
Agenus (Formerly known as Antigenics Inc. - New York) (AGEN)’ Prophage Vaccine For Glioma Hailed As A "Very Promising Therapy" In An Editorial Published In The Journal Neuro-Oncology 1/21/2014 9:11:33 AM
12345678910...
//-->